Navigation Links


licensed at Biology News

licensed at Biology Products
licensed at Biology Technology
licensed at Medicine News

Genomatix Licensed By Bayer Healthcare

Genomatix is a microarray platform which is now licensed by Bayer HealthCare. It enables biologists and bio-informaticians to analyze chip raw data//. It employs the latest genomic annotation. It combines both literature and pathway mining in a single coherent system. ‘After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector....

Test for Esophageal Reflux Licensed to Bayer by University

A new test for esophageal reflux disease developed by a Wake Forest University Health Sciences (WFUHS) otolaryngologist has been licensed to Bayer HealthCare’s Diagnostics Division by WFUHS.// The test, which detects the presence of human pepsin 3b in a patient’s saliva, was developed by Jamie Koufman, M.D., then professor of otolaryngology at Wake Forest University School of Medicine an...
licensed at Medicine Products
licensed at Medicine Technology

GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines

Investigational vaccine could offer protectionfor infants against type b andmeningococcal disease — GlaxoSmithKline (GSK) announced results from aPhase II vaccine clinical study presented this week at thePediatri...

CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal

LOS ANGELES--(BUSINESS WIRE)--Apr 23, 2007 - CytRx Corporation(NASDAQ:CYTR) today announced that the RNA interference (RNAi)delivery technology exclusively licensed to its majority-ownedsubsidiary, RXi Pharmaceuticals Corporation (RXi), has beenpublished in the April 2007 issue of peer-reviewed scientificjournal ACS Chemical Biology. The technology was developed by RXiCo-founder, Scientific...

Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR

Myriad Genetics Presents Studies Characterizing Vascular DisruptionCapabilities of Azixa(TM) TARRYTOWN, N.Y., April 20, 2007 /PRNewswire-FirstCall/ --EpiCept Corporation reported today that studies characterizing adual mode of action for Azixa(TM), a compound licensed by theCompany to Myriad Genetics, Inc. for the treatment of primary andsecondary brain tumors, were presented at the annua...
Other TagsClosureClosureSurveillance
(Date:11/17/2008)...io Biomedical Corporation (AMEX:INO), a leader in ...ctroporation-based DNA delivery, announced today t...tional interim results from its ongoing phase I/II...inst hepatitis C virus (HCV). This vaccine is bein...ased DNA delivery system. In the third and highest...
(Date:11/17/2008)...ships between scientists and the news media have e...ientists should continue to improve communications... to a Wake Forest University researcher whose comm...urnal. , David P. Friedman, Ph.D., professor of ...ity School of Medicine, says in the article that u...
(Date:11/17/2008)...ng a key lung test, experts say, , , ... three adults who,ve been told they have asthma ma...n research claims. , The study, published in th...on Journal , included nearly 500 adults from eight...percent of those diagnosed with asthma had been mi...
(Date:11/17/2008)...new exactly what a breast cancer cell needs to spr...the disease: metastasis. New research from the Uni... Medicine takes a step in that direction. , Caro...ty of breast cancer cells to migrate by knocking d..., They also found higher levels of palladin in f...
Breaking Medicine News(10 mins):Health News: Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases 2Health News: Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases 3Health News: Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases 4Health News:Award-winning researcher says relationships with news media, public are critical 2Health News:Award-winning researcher says relationships with news media, public are critical 3Health News:Nearly 1 in 3 Asthma Cases May Be Misdiagnosed 2Health News:Nearly 1 in 3 Asthma Cases May Be Misdiagnosed 3Health News:UNC researchers find clue to stopping breast-cancer metastasis 2
(Date:11/17/2008)...anding, California--Off the coast of Central Calif...ght orange metal pyramid about the size of two com...thin the metal pyramid is the heart of the Montere...-sea ocean observatory offshore of the continental...s in the making, the MARS Observatory went "live" ...
(Date:11/17/2008)...NA, Calif.--The bacterial cell wall that is the ta...ctually made up of a thin single layer of carbohyd...ap around the bacterium like a belt around a perso...t the California Institute of Technology (Caltech)...re in three dimensions was made possible by new hi...
(Date:11/17/2008)... are different, both physically and mentally, but ...the thought of scientists for decades now. But wit...n, the University of Alberta,s Tim Caulfield is co...attitudes. , Just last year Nobel Prize winning...esponsible for creating differences in human intel...
(Date:11/17/2008)...ech, Morocco, November 17, 2008 The International... (ICCAT) will meet from November 17- 24 in Marrake...Mediterranean bluefin tuna from collapse. , ICC...mpending collapse, with its own review panel sayin...hery is an "international disgrace" and a "travest...
Breaking Biology News(10 mins):New deep-sea observatory goes live 2New deep-sea observatory goes live 3New deep-sea observatory goes live 4Caltech researchers get first 3-D glimpse of bacterial cell-wall architecture 2Could genetic research awaken racist attitudes? 2Tuna Commission to decide the future of Mediterranean bluefin 2Revolutionary HD Surgical Footage from North Shore LIJ Surgeon to be Broadcast for the First Time on ABCs 20 20 National Geographic Channel 781 1Revolutionary HD Surgical Footage from North Shore LIJ Surgeon to be Broadcast for the First Time on ABCs 20 20 National Geographic Channel 781 2Tulane University to receive 2414M for international HIV AIDS program 780 1Tulane University to receive 2414M for international HIV AIDS program 780 2Multi Year Compendium of Pharmaceutical Case Studies Available from Best Practices LLC 776 1Multi Year Compendium of Pharmaceutical Case Studies Available from Best Practices LLC 776 2Pharmaceutical Manufacturing Quality 3A Optimizing Your Internal Process for FDA Compliance 772 1Pharmaceutical Manufacturing Quality 3A Optimizing Your Internal Process for FDA Compliance 772 2
Other Contentscochleacochleacochleacochleacodominantbiasbiasbiasbiascoelomcoenzymescoenzymescollateralcollateralcollateralcollateralcofactorscofactors